Attached files

file filename
10-K - FORM 10-K - rEVO Biologics, Inc.d10k.htm
EX-32 - CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 - rEVO Biologics, Inc.dex32.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - rEVO Biologics, Inc.dex312.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - rEVO Biologics, Inc.dex311.htm
EX-4.11 - AMENDED & RESTATED SECURED CONVERTIBLE NOTE - rEVO Biologics, Inc.dex411.htm
EX-10.37 - AMENDED & RESTATED PROMISSORY NOTE - rEVO Biologics, Inc.dex1037.htm
EX-10.43 - ATRYN GENERATION I CLINICAL & COMMERCIAL SERVICE AGREEMENT - rEVO Biologics, Inc.dex1043.htm
EX-10.42 - SERVICES AGREEMENT - rEVO Biologics, Inc.dex1042.htm
EX-10.29.1 - OMNIBUS AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT - rEVO Biologics, Inc.dex10291.htm
EX-10.38.1 - OMNIBUS AMENDMENT TO LOAN AGREEMENT - rEVO Biologics, Inc.dex10381.htm
EX-10.40.1 - SECOND AMENDMENT TO MORTGAGE AGREEMENT - rEVO Biologics, Inc.dex10401.htm
EX-21 - LIST OF SUBSIDIARIES - rEVO Biologics, Inc.dex21.htm

EXHIBIT 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File Nos. 33-82982, 33-97024, 333-25769, 333-49497, 333-51657, 333-59245, 333-94187, 333-50874, 333-108109, 333-111464, 333-127708, 333-129166, 333-135054, 333-142564, 333-142566) and Form S-8 (File Nos. 333-29059, 333-29975, 333-34119, 333-56749, 333-56747, 333-80623, 333-38490, 333-38494, 333-91468, 333-91470, 333-106066, 333-117923, 333-38484, 333-159510) of GTC Biotherapeutics, Inc. of our report dated March 12, 2010 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Annual Report on Form 10-K. We also consent to the reference to us under the heading “Selected Financial Data” in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts
March 12, 2010